✦ LIBER ✦

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

✍ Scribed by David Thomas; Robert Henshaw; Keith Skubitz; Sant Chawla; Arthur Staddon; Jean-Yves Blay; Martine Roudier; Judy Smith; Zhishen Ye; Winnie Sohn; Roger Dansey; Susie Jun

Book ID: 117785271
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 308 KB
Volume: 11
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(10)70010-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of denosumab for adu

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

✍ Chawla, Sant; Henshaw, Robert; Seeger, Leanne; Choy, Edwin; Blay, Jean-Yves; Fer 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 217 KB

An Open-Label, Prospective Pilot Clinica

An Open-Label, Prospective Pilot Clinical Study of Denosumab for Severe Hyperparathyroidism in Patients With Low Bone Mass Undergoing Dialysis

✍ Chen, Chien-Liang; Chen, Nai-Ching; Hsu, Chih-Yang; Chou, Kang-Ju; Lee, Po-Tsang 📂 Article 📅 2014 🏛 Endocrine Society 🌐 English ⚖ 409 KB

AOSOP6 Results from the 2-year open-labe

AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated with zoledronic acid or denosumab

✍ A.T. Stopeck; A. Lipton; M. Martín; J-J. Body; A. Paterson; G.G. Steger; K. Tonk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Denosumab Treatment for Giant Cell Tumor

Denosumab Treatment for Giant Cell Tumor of Bone (GCTB) in Adolescent Patients: Interim Results From a Phase II Study

✍ J. Enqellau; S. Chawla; R. Grimer; A. Powell; S. Schuetze; K. Skubitz; A. Staddo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB

An open-label phase I/II study of tamiba

An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma

✍ Fumihiko Kanai, Shuntaro Obi, Shigetoshi Fujiyama… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 476 KB

An open-label study of vandetanib with p

An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancer

✍ de Boer, R.; Humblet, Y.; Wolf, J.; Nogova, L.; Ruffert, K.; Milenkova, T.; Smit 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 136 KB